Navigation Links
Using additional biopsy-scoring data may help determine prostate cancer prognosis
Date:10/2/2007

Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the October 3 issue of JAMA.

One of the tools used for the diagnosis and treatment of prostate cancer is the Gleason scoring system, which grades adenocarcinomas (malignant tumors) of the prostate based on the patterns of prostatic glands. Many studies have confirmed the prognostic significance of the Gleason score with respect to time to recurrence and death following therapy, according to background information in the article. The Gleason scoring system assigns a grade of 1 to 5 (higher grade being less differentiated) to the predominant pattern and to the second most prevalent pattern in the prostate specimen. The two grades are summed to arrive at a final score between 2 and 10. Although the Gleason scoring system does not incorporate a third pattern, the presence of more than two Gleason patterns in an individual tumor is widely recognized to occur and many pathologists use a tertiary (third) pattern.

Abhijit A. Patel, M.D., Ph.D., of Brigham and Womens Hospital and the Dana Farber Cancer Institute, Boston, and colleagues conducted a study to compare the prognostic significance of Gleason score 7 with tertiary grade 5 vs. other Gleason scores with respect to time to prostate-specific antigen (PSA) failure (an increase in the blood level of PSA after prostate cancer treatment with surgery or radiation). From 1989 to 2005, 2,370 men with various tumor grades and prostate cancer that had not spread to nearby lymph nodes or elsewhere in the body, underwent therapy with surgery or radiation therapy with or without hormonal therapy. Gleason scores were assigned to the prostate needle biopsy specimens.

The researchers found that men with Gleason score 7 and tertiary grade 5 disease had a significantly shorter time to PSA failure than men with 7 without tertiary grade 5 (median [midpoint] time, 5.0 vs. 6.7 years, respectively); or score of 6 or less (median time, 15.4 years). However, a significant difference was not observed when these men were compared with men with Gleason score 8 to10 disease (median time, 5.1 years).

If these findings are validated by additional studies in other populations, they may affect the management of care for men with Gleason score 7 prostate cancer for which the currently practiced management standards include dose-escalated radiation therapy including prostate brachytherapy [radiation therapy where the radioactive source is placed inside the prostate] with or without supplemental radiation therapy, radiation therapy and short course androgen suppression therapy (AST) or radical prostatectomy. Specifically, given the time to recurrence, management options for men with Gleason score 7 who also have tertiary grade 5 disease could include treatments that are the current standards of care for men with Gleason 8 to 10 prostate cancer, the authors write.

These standards of care based on the results of randomized trials include radiation therapy and short- or extended-course AST or radical prostatectomy with the expectation that further therapy may be needed postoperatively depending on the final pathology findings of the radical prostatectomy and postoperative PSA level.


'/>"/>

Contact: Lori Shanks
617-534-1604
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
3. Researchers urge caution in using ear tube surgery
4. Surgery using gene therapy for Alzheimer’s patient
5. Protein causing spread of colon cancer identified
6. Relief to pregnant women using fertility drugs
7. The hazards of using disinfectant hand gel
8. Ulcer causing bug found in stored food
9. Colon cancer risk linked to genes causing Hemochromatosis
10. Teens Misusing Nicotine-Replacement Products
11. Head injury X-rays may actually be causing harm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... thrilled to formally announce its Not a Moment to Lose fundraising campaign. As ... rally supporters dedicated to declaring victory over cancer. The campaign aims to raise ...
(Date:12/6/2016)... ... 2016 , ... GrekTek LLC, ( http://www.grektek.com ) an mHealth ... ) for the HealthyWatch, a new device to help patients manage their health ... while sharing these events with caregivers in real time. , “One ...
(Date:12/6/2016)... Canada (PRWEB) , ... December 06, 2016 , ... ... announce the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS ... IAPC EHS audit protocols to understand the scope of their EHS regulatory obligations ...
(Date:12/5/2016)... ... December 05, 2016 , ... What: Shriners Hospitals for Children, ... Pole to our patients – using a video monitor and web-enabled camera. Santa visits ... transform the Auditorium into a Christmas Wonderland, which is where the video connection to ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., ... in SuperbCrew magazine, a leading online tech news platform connecting technology innovators with ... on SuperbCrew.com, explores the state of enterprise mobility security today, and how the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016   TrainerMD , the first ... announced a new collaboration with Styku . Styku, ... leverages Microsoft Kinect hardware to provide users world-class, real-time 3D body ... now have the means to see, hear and feel their health ... , ...
(Date:12/5/2016)... 5, 2016  Recently Zymo Research announced an ... known as Horvath,s Clock. Based on this technology, ... service to academic and biopharma scientific researchers to ... other than sperm. The service quantifies ... age versus chronological age following drug treatments and ...
(Date:12/5/2016)... -- For the third consecutive year, Astellas has achieved ... Campaign Foundation,s (HRC) annual Corporate Equality Index ... used to rate companies on policies and practices concerning ... For the last 15 years, HRC has released ... efforts, culture and business practices. The survey rates business ...
Breaking Medicine Technology: